Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by medvic1on May 26, 2020 12:37pm
192 Views
Post# 31073573

RE:RE:Too Soon eh!

RE:RE:Too Soon eh!It is quite realistic view as for me. The last financing was terrible. I would say if general stock market will slide into recession, who knows what dip it can be, 0.60 - 0.70c is the most we can hope. Another financing is guaranteed and 1:10 split too, mark my words. BUT, BUT, those who holds and accumulate will win.
My story with CVM: hold about 50,000shares at 0.35c for many years,1:10 split come, after couple yers at Ph3 1:25 split again. So, I ended up buying 1500shares at $7.15 last year. Awaiting FDA approval now, if success - PS will jump over $100 - $200, if fail - $1. 
So, if you believe in TLT - hold it and accumulate at funny price like it was at 0.16c. I'm done with TLT trading and my 60k shares locked, for now..., my average 0.27c.

nemo3 wrote: Yes, TLT is very frustrating. Besides being hammered by the halt of TLT's application to the FDA that took 6 months to iron out, we were also slammed by COVID-19 which caused a temporary cessation of the Phase 2 clinical trial. We don't know when new patients will be brought in and treated.  And seems the patients treated so far may not get the second treatment at 6 months. It may be that all patients treated and making the 1 year mark post treatment might not be completed until 2022. I think the market has spoken that currently there is little confidence in TLT. I think given the way it currently trades, previous thoughts by some that this stock would reach $100 is but an unrealistic dream. I want to see 60 cents and then maybe if things all went well in 2021 or 2022 we could see TLT at a couple of bucks. Because with this delay TLT may well run out of money before the end of the current Ph 2 study and have to do another financing which will create far too many outstanding shares to create the value we are all waiting for. So I will continue to hold and hope that in the next year or so my frustration will be rewarded by at least 10 times the current value. 


Bullboard Posts